← Leaderboards
Sunil David
University Of Kansas Lawrence
$17,409,487
Attributed
$17,409,487
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.4M · FY2009–18$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$17,409,487 · 2
By mechanism
N01$17,409,487 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Lead”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Charles Mattias Mountain · Association Of Universities For Research In Astronomy, Inc.$423,098,075
- David Heimbrook · Leidos Biomedical Research, Inc.$406,926,511
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$382,410,253
Research focus
LeadProgramsAdjuvantHigh Throughput ScreeningValidationAnimal ModelSignal PathwayReceptorVaccine AdjuvantStructure-Activity RelationshipPharmaceutical ChemistryVaccinesBaseCellsIn VivoVaccine CandidateOryctolagus CuniculusFormulationDiphtheria ToxinContractsContractorImmunologic AdjuvantsCommunicable DiseasesAntigens
Grant awards (7)
Adjuvant Discovery For Diphtheria Toxin Vaccine and Zika Vaccine$1,255,650
N01 · FY2018 · AI · contact PI
Adjuvant discovery: Zika$300,000
N01 · FY2017 · AI · contact PI
Adjuvant discovery: Zika$400,001
N01 · FY2016 · AI · contact PI
Adjuvant Discovery For Diphtheria Toxin Vaccine$8,353,317
N01 · FY2014 · AI · contact PI
Novel adjuvants acting through TLR2, TLR5 and TLR7 receptors$1,344,542
N01 · FY2013 · AI · contact PI
Novel adjuvants acting through TLR2, TLR5 and TLR7 receptors$250,000
N01 · FY2011 · AI · contact PI
Novel adjuvants acting through TLR2, TLR5 and TLR7 receptors$5,505,977
N01 · FY2009 · AI · contact PI